Filing Details

Accession Number:
0001127602-22-025770
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-16 16:27:42
Reporting Period:
2022-11-14
Accepted Time:
2022-11-16 16:27:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
859737 Hologic Inc HOLX X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844) 042902449
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1630909 M. John Griffin 250 Campus Drive
Marlborough MA 01752
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-14 26,902 $40.85 195,846 No 4 M Direct
Common Stock Disposition 2022-11-14 23,634 $76.07 172,212 No 4 S Direct
Common Stock Disposition 2022-11-14 3,268 $76.49 168,944 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-qualified Stock Option (Right to Buy) Disposition 2022-11-14 26,902 $0.00 26,902 $40.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-12-01 No 4 M Direct
Footnotes
  1. Includes 46,727 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
  2. The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $75.62 to $76.355 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
  3. The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $76.36 to $76.73 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
  4. This option to purchase common stock became exercisable in equal installments on each of the first four anniversaries of the grant date, December 1, 2017.